Clinical Updates in Cardiac Electrophysiology

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 11 October 2024 | Viewed by 1912

Special Issue Editor


E-Mail Website
Guest Editor
Division of Cardiovascular Medicine, University of Virginia Health System, 1215 Lee Street, Charlottesville, VA, USA
Interests: arrhythmias; heart rhythm disorders; atrial fibrillation (Afib); catheter ablation; heart devices for Afib; pacemakers; conduction system pacing; left bundle branch area pacing; artificial intelligence; digital health; cardiac magnetic resonance; supraventricular tachycardia; sudden cardiac arrest; ventricular tachycardia; heart genetics

Special Issue Information

Dear Colleagues,

The Journal of Clinical Medicine (a renowned journal with an impact score of 4.1 and a CiteScore of 5.4) is pleased to announce a new Special Issue titled ‘Clinical Advancements in Cardiac Electrophysiology.’ In recent years, there have been significant developments in the fields of catheter ablation, conduction system pacing, left atrial appendage occlusion, leadless pacing, remote monitoring, artificial intelligence, and digital health. These improvements are expected to have a major impact for patients with heart rhythm disorders and heart failure in the coming years, and thus, dissemination of these findings to a broad readership is crucial.

Therefore, this Special Issue invites original research and systematic reviews to provide an update on the clinical progress related to treatment approaches, predictors of outcomes, advanced cardiac imaging including cardiac magnetic resonance, remote monitoring, digital health, and artificial intelligence for heart rhythm disorders.

Prof. Dr. Kenneth C. Bilchick
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • arrhythmias
  • atrial fibrillation
  • cardiac electrophysiology
  • heart rhythm disorders
  • ablation
  • ventricular tachycardia
  • remote monitoring
  • digital health
  • artificial intelligence
  • cardiac magnetic resonance

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 3439 KiB  
Article
Transesophageal Echocardiography Improves Precision in Transseptal Puncture Compared to Fluoroscopy in Left Atrial Electrophysiological Procedures
by Lyuboslav Katov, Yannick Teumer, Katrin Lederbogen, Rima Melnic, Wolfgang Rottbauer, Carlo Bothner and Karolina Weinmann-Emhardt
J. Clin. Med. 2024, 13(9), 2476; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm13092476 - 24 Apr 2024
Viewed by 242
Abstract
Background: Complex arrhythmias often arise from the left side of the heart, necessitating established electrophysiological (EP) procedures like 3D-mapping-assisted radiofrequency (RF) ablations or pulmonary vein isolation (PVI). These procedures typically require transseptal access, emphasizing the critical role of achieving an optimal catheter position [...] Read more.
Background: Complex arrhythmias often arise from the left side of the heart, necessitating established electrophysiological (EP) procedures like 3D-mapping-assisted radiofrequency (RF) ablations or pulmonary vein isolation (PVI). These procedures typically require transseptal access, emphasizing the critical role of achieving an optimal catheter position through a precise transseptal puncture (TSP). Commonly employed imaging methods for TSP guidance include fluoroscopy and interventional echocardiography. Despite their routine use, there is limited evidence on which imaging modality offers superior catheter positioning for EP procedures, and safety concerns regarding transseptal punctures with imaging remain underexplored. This study aims to systematically evaluate the feasibility, safety, and accuracy of echo-guided TSP compared to fluoroscopy-guided TSP. Methods: In this prospective study, 150 consecutive patients undergoing left atrial EP procedures were enrolled between October 2023 and February 2024 at the Ulm University Heart Center. Following optimal fluoroscopy-guided transseptal needle positioning at the interatrial septum, the catheter placement was further verified using transesophageal echocardiography (TEE). Adjustments were made in cases of suboptimal needle positioning observed in TEE. The fluoroscopically achieved septal positions were categorized based on TEE images as optimal, suboptimal, poor, or dangerous. Results: Among the 150 patients included (58.0% male), fluoroscopy achieved optimal, suboptimal, and poor/dangerous positions in 32.7%, 43.3%, and 24.0%, respectively. After TEE-guided adjustments, optimal and suboptimal positions were achieved in 59.3% and 40.7% of patients, respectively. No instances of poor or dangerous transseptal needle positions were observed under TEE guidance. Conclusions: TEE-guided TSP emerges as a feasible, more accurate, and safer imaging method for transseptal punctures in EP procedures. Full article
(This article belongs to the Special Issue Clinical Updates in Cardiac Electrophysiology)
Show Figures

Figure 1

9 pages, 557 KiB  
Article
Pulmonary Vein Isolation with a Novel Size-Adjustable Cryo-Balloon Catheter: A Tailored Ablation Protocol
by Yannick Teumer, Franziska Hilgarth, Lyuboslav Katov, Rima Melnic, Wolfgang Rottbauer, Carlo Bothner and Karolina Weinmann
J. Clin. Med. 2024, 13(8), 2262; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm13082262 - 13 Apr 2024
Viewed by 288
Abstract
Background: Pulmonary vein isolation (PVI) is a common therapeutic approach for symptomatic atrial fibrillation (AF). Among various techniques, cryo-balloon (CB) PVI is widely adopted, but, to date, established CB systems have had fixed balloon sizes. A novel size-adjustable CB, allowing balloon size adjustments [...] Read more.
Background: Pulmonary vein isolation (PVI) is a common therapeutic approach for symptomatic atrial fibrillation (AF). Among various techniques, cryo-balloon (CB) PVI is widely adopted, but, to date, established CB systems have had fixed balloon sizes. A novel size-adjustable CB, allowing balloon size adjustments during ablation, lacks sufficient data on optimal utilization in patient care. This study aims to systematically investigate this feature with a tailored ablation protocol. Methods: Our single-center prospective study included patients with paroxysmal or persistent atrial fibrillation undergoing first-time PVI with the size-adjustable CB from July 2023 to February 2024. Ablation was performed using the balloon size that provided better occlusion. The ablation protocol involved an initial occlusion test with the small balloon size (28 mm). If optimal occlusion (occlusion level 4) could not be achieved, an attempt with the larger balloon (31 mm) was initiated. Ablation was conducted using the balloon configuration that provided better occlusion of the pulmonary vein ostium. Results: Our prospective study includes 50 patients (median age [interquartile range, IQR]: 72 [65; 79] years, 24 [48.0%] females, and 35 [70.0%] patients with paroxysmal AF). The median procedure duration (IQR) was 77 (65; 96) minutes, and the median fluoroscopy time (IQR) was 17.7 (12.5; 22.0) min. PVI was successfully accomplished in each treated pulmonary vein (PV), with 87.4% of PVs isolated during the first freeze. The large balloon configuration was used to isolate 16.8% of PVs. Conclusions: The utilization of the size-adjustable CB, combined with the presented tailored ablation workflow, appears to facilitate effective and efficient pulmonary vein isolation. The use of a larger balloon configuration appears beneficial in isolating a significant proportion of the PVs. Full article
(This article belongs to the Special Issue Clinical Updates in Cardiac Electrophysiology)
Show Figures

Graphical abstract

11 pages, 799 KiB  
Article
Comparison between a Novel Radiofrequency-Balloon and a Standard Cryo-Balloon in Pulmonary Vein Isolation: A Propensity-Score-Matched Analysis
by Yannick Teumer, Clemens Miesbichler, Lyuboslav Katov, Benjamin Mayer, Wolfgang Rottbauer, Carlo Bothner and Karolina Weinmann
J. Clin. Med. 2024, 13(4), 963; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm13040963 - 08 Feb 2024
Viewed by 508
Abstract
Background/Objectives: Single-shot devices are important tools for efficient pulmonary vein isolation (PVI) in atrial fibrillation (AF). In addition to the standard cryo-balloon (CB) catheter, a novel multi-electrode radiofrequency balloon-catheter (RFB, Heliostar, Biosense Webster, Irvine, CA, USA) with 3D-mapping-integration is available. Currently, there [...] Read more.
Background/Objectives: Single-shot devices are important tools for efficient pulmonary vein isolation (PVI) in atrial fibrillation (AF). In addition to the standard cryo-balloon (CB) catheter, a novel multi-electrode radiofrequency balloon-catheter (RFB, Heliostar, Biosense Webster, Irvine, CA, USA) with 3D-mapping-integration is available. Currently, there is no evidence allowing for a direct comparison between RFB-PVI and CB-PVI in a matched population. The study aimed to assess the procedural data, safety profiles, and outcomes of RFB-PVI versus CB-PVI. Methods: In this prospective registry study, symptomatic AF patients undergoing first-time PVI from January 2019 to April 2023, using RFB or CB, were included, with patients matched in a 1:2 ratio to reduce potential confounders. Results: The results from 171 consecutive RFB patients and 342 matched CB patients showed comparable recurrence-free survival after 12 months (81.3% RFB vs. 76.8% CB, p = 0.359). The RFB group had a longer procedure duration (88 vs. 73 min, p < 0.001) and longer fluoroscopy time (18.9 vs. 14.5 min, p < 0.001). Conclusions: In conclusion, the novel RFB system enables efficient and safe PVI, which is broadly comparable to the established CB system. However, the 3D-mapping integration in RFB did not reduce fluoroscopy time compared to CB. Full article
(This article belongs to the Special Issue Clinical Updates in Cardiac Electrophysiology)
Show Figures

Figure 1

12 pages, 1834 KiB  
Article
Atrial Fibrillation Ablation with a Novel Fully 3D-Mapping-Integrated Multi-Electrode Radiofrequency Balloon Catheter
by Yannick Teumer, Clemens Miesbichler, Andreas Hauke, Lyuboslav Katov, Carlo Bothner, Alexander Pott, Martin Müller, Benjamin Walter, Wolfgang Rottbauer, Tillman Dahme and Karolina Weinmann
J. Clin. Med. 2024, 13(1), 207; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm13010207 - 29 Dec 2023
Cited by 1 | Viewed by 630
Abstract
Pulmonary vein isolation (PVI), as the cornerstone of atrial fibrillation (AF) ablation, has emerged a widely used therapy for patients suffering from AF. To improve PVI efficiency, single-shot catheters (SSCs) have been developed. Regrettably, SSCs are not integrated into 3D-mapping technology. In that [...] Read more.
Pulmonary vein isolation (PVI), as the cornerstone of atrial fibrillation (AF) ablation, has emerged a widely used therapy for patients suffering from AF. To improve PVI efficiency, single-shot catheters (SSCs) have been developed. Regrettably, SSCs are not integrated into 3D-mapping technology. In that regard, a novel radiofrequency balloon catheter (RFBC, Heliostar, Biosense Webster) with full integration into 3D-mapping technology has been developed. The aim of this study was to assess operative and follow-up outcomes of the RFBC in AF patients. In this monocentric prospective registry, patients with a first-time PVI using the RFBC were included. Follow-up visits were scheduled 3, 6, 12 and 24 months after ablation and in case of symptoms. A total of 171 patients (36.8% female) were included, with a mean age of 68.5 ± 10.2 years. Among them, 63 patients (36.8%) presented with persistent AF. Notably, no major periprocedural complications were observed. The mean follow-up period was 287 ± 157 days. In the Kaplan–Meier analysis, the estimated recurrence-free survival after 12 months was 81.8%. Based on our data, PVI with the fully 3D-mapping-integrated RFBC seems to be safe and effective and to have a favorable 12-month outcome in patients with paroxysmal and persistent AF. Full article
(This article belongs to the Special Issue Clinical Updates in Cardiac Electrophysiology)
Show Figures

Figure 1

Back to TopTop